Transmission and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak
Abstract
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unmatched challenges to the healthcare systems in almost every country around the world. Currently, there are no established effective vaccines or therapeutic agents against the virus. Present clinical management includes infection prevention and control process and supportive care including supplemental oxygen and mechanical ventilator support. It is proposed this is likely the zoonotic beginning of COVID-19. Individual to-individual transmission of COVID-19 contamination prompted the separation of patients that were accordingly managed an assortment of medicines.
Keywords: COVID-19, SARS-CoV-2, supplemental oxygen, ventilator support
Keywords:
COVID-19, SARS-CoV-2, supplemental oxygen, ventilator supportDOI
https://doi.org/10.22270/jddt.v10i6.4577References
Su S, Wong G, Shi W, Liu J, Lai A, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Elsevier [Internet]. [cited 2020 Sep 4]; Available from: https://www.sciencedirect.com/science/article/pii/S0966842X16000718
Wu R, Wang L, Kuo H, Shannar A, … RP-CP, 2020 undefined. An update on current therapeutic drugs treating COVID-19. Springer [Internet]. [cited 2020 Aug 25]; Available from: https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf
Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Vol. 16, Virology Journal. BioMed Central Ltd.; 2019.
Weiss SR, Navas-Martin S. Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol Mol Biol Rev [Internet]. 2005 [cited 2020 Sep 5]; 69(4):635–64. Available from: http://mmbr.asm.org/
An update on current therapeutic drugs treating COVID-19. Springer [Internet]. [cited 2020 Sep 5]; Available from: https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf
Eissenberg T, Kanj SS, Shihadeh AL. Treat COVID-19 as Though It Is Airborne: It May Be. AANA journal. NLM (Medline); 2020; 88:29–30.
Morawska L, International JC-E, 2020 undefined. Airborne transmission of SARS-CoV-2: The world should face the reality. Elsevier [Internet]. [cited 2020 Sep 5]; Available from: https://www.sciencedirect.com/science/article/pii/S016041202031254X
Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community Transmission of SARS-CoV-2. 2020 [cited 2020 Sep 6]; Available from: https://doi.org/10.1016/S0140-6736
Jama LB-, 2020 undefined. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. jamanetwork.com [Internet]. [cited 2020 Sep 6]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2763852
Ong S, Tan Y, Chia P, Lee T, Jama ON-, 2020 undefined. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic. jamanetwork.com [Internet]. [cited 2020 Sep 6]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2762692
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 Feb [cited 2020 Sep 6];395(10223):497–506. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620301835
Sanders J, Monogue M, Jodlowski T, Jama JC-, 2020 undefined. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. jamanetwork.com [Internet]. [cited 2020 Aug 25]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2764727
Rothan H, autoimmunity SB-J of, 2020 undefined. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Elsevier [Internet]. [cited 2020 Sep 6]; Available from: https://www.sciencedirect.com/science/article/pii/S0896841120300469
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Elsevier [Internet]. [cited 2020 Aug 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0140673620301835
Ronco C, Nephrology TR-NR, 2020 undefined. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. nature.com [Internet]. [cited 2020 Aug 24]; Available from: https://www.nature.com/articles/s41581-020-0284-7
Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. jamanetwork.com [Internet]. [cited 2020 Aug 24]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2762028
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, international LD-K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Elsevier [Internet]. [cited 2020 Aug 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0085253820302556
Kumar A, Zarychanski R, Pinto R, Cook D, Jama JM-, 2009 undefined. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. jamanetwork.com [Internet]. [cited 2020 Aug 24]; Available from: https://jamanetwork.com/journals/jama/article-abstract/184799
Published
Abstract Display: 554 
PDF Downloads: 669 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.